Norway's June core inflation slightly higher than expected
Core inflation, which strips out changing energy prices and taxes, stood at 3.1 per cent year-on-year, up from 2.8 per cent in May and above the 3.0 per cent expected by analysts in a Reuters poll.
Norges Bank had expected core inflation of 3.1 per cent.
Norway's crown currency traded largely unchanged against the euro at 11.83 at 0608 GMT, following the 0600 GMT data release.
Norway's central bank in June cut its policy interest rate to 4.25 per cent and said there were more cuts to come due to a more benign inflation outlook – a decision that took most analysts by surprise.
Norges Bank, which targets core inflation of 2.0 per cent, said at the time that the policy rate would be reduced further this year if the economy evolved broadly as projected.
The central bank is scheduled to make its next policy rate announcement on Aug 14.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
4 hours ago
- The Star
South Africa continues tariff negotiation with U.S.
JOHANNESBURG, Aug. 1 (Xinhua) -- With a 30-percent tariff imposed by the United States set to take effect, South African President Cyril Ramaphosa on Friday pledged to pursue all diplomatic efforts to safeguard the national interests. According to a statement released by the presidency, South Africa will continue to negotiate with the United States regarding the 30 percent tariff, which is now expected to take effect at 12:01 a.m. EDT (0401 GMT) on Aug. 7. The South African government has presented the U.S. side with a framework deal aimed at enhancing mutually beneficial trade and investment relations. "All channels of communication remain open to engage with the United States, and our negotiators are ready, pending an invitation from the United States," the presidency said in the statement. The presidency noted that the South African government is finalizing a package to support companies vulnerable to reciprocal tariffs, which includes several measures to assist firms, producers, and workers. "South Africa will continue to pursue all diplomatic efforts to safeguard its national interests," said the presidency. On Tuesday, the South African government acknowledged that "the intersection of geopolitical, domestic and trade issues" defines the current impasse between the two sides. Relations between South Africa and the United States have taken a downturn since U.S. President Donald Trump took office in January. Trump indicated that he may skip the Group of 20 Summit, which will be held in November in Johannesburg, the largest city and economic hub of South Africa.
The Sun
9 hours ago
- The Sun
European drugmakers drop as Trump pushes for US price cuts
SINGAPORE: Shares of European drugmakers slipped on Friday after U.S. President Donald Trump sent letters to major pharmaceutical firms to cut drug prices in the United States, months after signing a sweeping executive order aimed at lowering prices. The letters were the latest setback for a sector still grappling with the prospect of tariffs outlined in the U.S.-EU trade deal that could cost the pharmaceutical industry between $13 billion and $19 billion. Trump called on 17 drugmakers to provide so-called most-favoured-nation prices to every patient enrolled in the government Medicaid health programme for low-income people, and to guarantee such pricing for new drugs. Shares of European drugmakers Sanofi, AstraZeneca , GSK, Merck KGaA and Novo Nordisk slipped between around 1% and 4% in early trading on Friday. Novo's 4% fall extends a selloff this week that started on Tuesday with a 28% plunge, wiping out $70 billion of its market value after the maker of weight-loss drug Wegovy issued a profit warning and named a new CEO. The companies were all sent letters by Trump, who gave them until September 29 to respond with binding commitments to those terms. U.S. drugmakers including Pfizer, Johnson & Johnson, Eli Lilly and Merck were also sent the letters. The European healthcare index was down 1.4% by 0731 GMT, its lowest since April. 'Trump's directive to the pharma companies will put them on the defensive and adds yet another layer of uncertainty for the sector which could also face import tariffs in time to come,' said Vasu Menon, managing director of investment strategy at OCBC. 'While Trump has set a deadline for these companies to comply, it remains to be seen if this is hard coded or if he will roll back some of his threats if these companies make an effort to engage him and soften his stance.' Analysts, lobbyists and drug pricing experts though said it seemed unlikely that the pharmaceutical companies would comply with Trump's demand to lower U.S. prices. The companies including Pfizer, AbbVie, and German Merck KGaA's U.S. division, EMD Serono, said they were open to working with the Trump administration. Trump's executive order in May directed drugmakers to lower medicine prices to align with what other countries pay, leading to some shift in how drugmakers look to sell their medicines. Swiss drugmaker Roche said last week it was considering selling its prescription medicines in the United States directly to consumers to lower costs for patients as part of talks with the U.S. government. - Reuters
The Sun
12 hours ago
- The Sun
Oil steady as tariff worries offset Russian supply fears
OIL prices were little changed on Friday after falling more than 1% in the previous session as traders digested the impact of higher U.S. tariffs that may curtail economic activity and lower global fuel demand growth. Brent crude futures were down 7 cents, or 0.1%, to $71.63 a barrel at 0656 GMT. U.S. West Texas Intermediate crude was down 10 cents, or 0.14%, to $69.16 a barrel. Still, Brent prices are set to gain 4.9% for the week while WTI is set to climb 6.4% after U.S. President Donald Trump earlier this week threatened to place tariffs on buyers of Russian crude, particularly China and India, to try to pressure Russia into halting its war against Ukraine. 'We think the resolution of trade deals to the satisfaction of the market – more or less, barring a few exceptions – has been the key driver for oil price bullishness in recent days, and further progress on trade talks with China in future could be a further confidence booster for the oil market,' said Suvro Sarkar, energy sector team lead at DBS bank. On Friday though, investors were more focused on Trump's imposition of new, and mostly higher, tariff rates on U.S. trading partners set to go into effect from August 1. Trump signed an executive order on Thursday imposing tariffs ranging from 10% to 41% on U.S. imports from dozens of countries and foreign territories including Canada, India and Taiwan that failed to reach trade deals by his deadline of August 1. Some analysts have warned the levies will limit economic growth by raising prices, which could weigh on oil consumption. On Thursday, there were signs that existing tariffs are already pushing prices higher in the U.S., the world's biggest economy and oil consumer. U.S. inflation increased in June as tariffs boosted prices for imported goods such as household furniture and recreation products. This is supporting views that price pressures could pick up in the second half of the year and delay Federal Reserve interest rate cuts until at least October. Maintaining interest rates could also impact oil as higher borrowing costs can limit economic growth. At the same time, Trump's threats to impose 100% secondary tariffs on Russian crude buyers have supported prices because of concerns that would disrupt oil trade flows and remove some oil from the market. DBS' Sarkar said that India's slowing of Russian imports may lead to some supply curtailment, but that that would be mostly negated by Chevron resuming oil production in Venezuela, record U.S. production, and growing U.S. supply. JP Morgan analysts said in a note on Thursday that Trump's warnings to China and India of penalties on their ongoing purchases of Russian oil potentially put 2.75 million barrels per day of Russian seaborne oil exports at risk. The two countries are the world's second- and third-largest crude consumers, respectively. 'The Trump administration, like its predecessors, will likely find sanctioning the world's second-largest oil exporter unfeasible without spiking oil prices,' the analysts said, referring to Russia. - Reuters
